Biomarin Pharmaceutical IncNASDAQ:BMRN
- LAST PRICE91.2000
- TODAY'S CHANGE (%)-0.8600 (-0.9342%)
- Bid / Lots87.7000/ 2
- Ask / Lots88.0000/ 1
- Open / Previous Close92.6900 / 92.0600
- Day Range
- 52 Week Range
- Volume1,599,587
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BMRN |
|---|---|---|
| 09:32 ET | 14939 | 92.06 |
| 09:34 ET | 2918 | 92.12 |
| 09:36 ET | 2325 | 92.03 |
| 09:38 ET | 2800 | 92.045 |
| 09:39 ET | 200 | 92.1 |
| 09:41 ET | 1851 | 92.35 |
| 09:43 ET | 7368 | 92.45 |
| 09:45 ET | 2291 | 92.41 |
| 09:48 ET | 926 | 92.25 |
| 09:50 ET | 400 | 92.295 |
| 09:52 ET | 3001 | 92.44 |
| 09:54 ET | 1560 | 92.46 |
| 09:56 ET | 6875 | 92.335 |
| 09:57 ET | 1000 | 92.26 |
| 09:59 ET | 8205 | 92.11 |
| 10:01 ET | 500 | 92.14 |
| 10:03 ET | 2700 | 92.38 |
| 10:06 ET | 2820 | 92.4125 |
| 10:08 ET | 1811 | 92.6 |
| 10:10 ET | 1100 | 92.61 |
| 10:12 ET | 3707 | 92.78 |
| 10:14 ET | 500 | 92.89 |
| 10:15 ET | 59705 | 92.78 |
| 10:17 ET | 1400 | 92.78 |
| 10:19 ET | 3985 | 92.74 |
| 10:21 ET | 2240 | 92.66 |
| 10:24 ET | 900 | 92.67 |
| 10:26 ET | 4005 | 92.61 |
| 10:28 ET | 1498 | 92.72 |
| 10:30 ET | 17585 | 92.735 |
| 10:32 ET | 1500 | 92.615 |
| 10:33 ET | 700 | 92.54 |
| 10:35 ET | 3181 | 92.53 |
| 10:37 ET | 5764 | 92.59 |
| 10:39 ET | 4254 | 92.47 |
| 10:42 ET | 4077 | 92.45 |
| 10:44 ET | 1500 | 92.4 |
| 10:46 ET | 1015 | 92.43 |
| 10:48 ET | 1900 | 92.38 |
| 10:50 ET | 200 | 92.435 |
| 10:51 ET | 800 | 92.45 |
| 10:53 ET | 1900 | 92.405 |
| 10:55 ET | 1200 | 92.36 |
| 10:57 ET | 951 | 92.41 |
| 11:00 ET | 1133 | 92.5 |
| 11:02 ET | 4657 | 92.41 |
| 11:04 ET | 2613 | 92.34 |
| 11:06 ET | 1198 | 92.325 |
| 11:08 ET | 800 | 92.34 |
| 11:09 ET | 3334 | 92.23 |
| 11:11 ET | 1500 | 92.23 |
| 11:13 ET | 300 | 92.19 |
| 11:15 ET | 1300 | 92.1 |
| 11:18 ET | 2577 | 92.09 |
| 11:20 ET | 100 | 92.07 |
| 11:22 ET | 1297 | 92.065 |
| 11:24 ET | 1141 | 92.11 |
| 11:26 ET | 868 | 92.17 |
| 11:27 ET | 1202 | 92.17 |
| 11:29 ET | 1200 | 92.23 |
| 11:31 ET | 1571 | 92.055 |
| 11:33 ET | 1607 | 92.04 |
| 11:36 ET | 2500 | 91.98 |
| 11:38 ET | 638 | 91.97 |
| 11:40 ET | 1226 | 91.98 |
| 11:42 ET | 1928 | 91.97 |
| 11:44 ET | 927 | 91.87 |
| 11:47 ET | 1400 | 91.74 |
| 11:49 ET | 3860 | 91.68 |
| 11:51 ET | 2100 | 91.84 |
| 11:54 ET | 3100 | 91.75 |
| 11:56 ET | 3620 | 91.58 |
| 11:58 ET | 3256 | 91.58 |
| 12:00 ET | 1200 | 91.46 |
| 12:02 ET | 3030 | 91.51 |
| 12:03 ET | 1326 | 91.59 |
| 12:05 ET | 4479 | 91.585 |
| 12:07 ET | 1549 | 91.61 |
| 12:09 ET | 2455 | 91.59 |
| 12:12 ET | 709 | 91.59 |
| 12:14 ET | 2725 | 91.59 |
| 12:16 ET | 400 | 91.615 |
| 12:18 ET | 2700 | 91.6 |
| 12:20 ET | 1026 | 91.6 |
| 12:21 ET | 3613 | 91.57 |
| 12:23 ET | 1700 | 91.52 |
| 12:25 ET | 1747 | 91.53 |
| 12:27 ET | 2514 | 91.51 |
| 12:30 ET | 2505 | 91.39 |
| 12:32 ET | 2027 | 91.38 |
| 12:34 ET | 7205 | 91.25 |
| 12:36 ET | 700 | 91.21 |
| 12:38 ET | 3000 | 91.16 |
| 12:39 ET | 1800 | 91.21 |
| 12:41 ET | 2500 | 91.01 |
| 12:43 ET | 1260 | 91.01 |
| 12:45 ET | 1200 | 91.07 |
| 12:48 ET | 2149 | 91.04 |
| 12:50 ET | 2235 | 91.27 |
| 12:52 ET | 2000 | 91.21 |
| 12:54 ET | 1647 | 91.24 |
| 12:56 ET | 1800 | 91.2 |
| 12:57 ET | 1150 | 91.19 |
| 12:59 ET | 2757 | 91.24 |
| 01:01 ET | 1818 | 91.29 |
| 01:03 ET | 4447 | 91.2099 |
| 01:06 ET | 1377 | 91.2 |
| 01:08 ET | 1525 | 91.17 |
| 01:10 ET | 2300 | 91.16 |
| 01:12 ET | 4142 | 91.195 |
| 01:14 ET | 1700 | 91.225 |
| 01:15 ET | 2903 | 91.23 |
| 01:17 ET | 3554 | 91.31 |
| 01:19 ET | 2342 | 91.4 |
| 01:21 ET | 2153 | 91.325 |
| 01:24 ET | 3357 | 91.33 |
| 01:26 ET | 1100 | 91.31 |
| 01:28 ET | 1700 | 91.33 |
| 01:30 ET | 2439 | 91.39 |
| 01:32 ET | 2595 | 91.46 |
| 01:33 ET | 5800 | 91.52 |
| 01:35 ET | 2237 | 91.44 |
| 01:37 ET | 2414 | 91.46 |
| 01:39 ET | 1761 | 91.49 |
| 01:42 ET | 4493 | 91.59 |
| 01:44 ET | 3018 | 91.65 |
| 01:46 ET | 2891 | 91.565 |
| 01:48 ET | 2332 | 91.56 |
| 01:50 ET | 1726 | 91.5439 |
| 01:51 ET | 4698 | 91.68 |
| 01:53 ET | 4569 | 91.73 |
| 01:55 ET | 500 | 91.78 |
| 01:57 ET | 3710 | 91.78 |
| 02:00 ET | 3600 | 91.83 |
| 02:02 ET | 3116 | 91.77 |
| 02:04 ET | 4500 | 91.64 |
| 02:06 ET | 2943 | 91.515 |
| 02:08 ET | 2000 | 91.53 |
| 02:09 ET | 1200 | 91.47 |
| 02:11 ET | 2876 | 91.515 |
| 02:13 ET | 1961 | 91.43 |
| 02:15 ET | 3832 | 91.35 |
| 02:18 ET | 4701 | 91.38 |
| 02:20 ET | 978 | 91.36 |
| 02:22 ET | 3429 | 91.42 |
| 02:24 ET | 2407 | 91.455 |
| 02:26 ET | 4820 | 91.395 |
| 02:27 ET | 2470 | 91.4 |
| 02:29 ET | 2970 | 91.34 |
| 02:31 ET | 3950 | 91.25 |
| 02:33 ET | 5829 | 91.285 |
| 02:36 ET | 3300 | 91.355 |
| 02:38 ET | 4716 | 91.3 |
| 02:40 ET | 2490 | 91.34 |
| 02:42 ET | 5002 | 91.43 |
| 02:44 ET | 3752 | 91.4 |
| 02:45 ET | 1700 | 91.39 |
| 02:47 ET | 3061 | 91.41 |
| 02:49 ET | 11330 | 91.24 |
| 02:51 ET | 6775 | 91.22 |
| 02:54 ET | 5053 | 91.25 |
| 02:56 ET | 6517 | 91.24 |
| 02:58 ET | 1960 | 91.28 |
| 03:00 ET | 2681 | 91.2 |
| 03:02 ET | 3732 | 91.21 |
| 03:03 ET | 3910 | 91.145 |
| 03:05 ET | 3292 | 91.14 |
| 03:07 ET | 2353 | 91.11 |
| 03:09 ET | 5350 | 91.19 |
| 03:12 ET | 3700 | 91.205 |
| 03:14 ET | 1883 | 91.18 |
| 03:16 ET | 3134 | 91.2075 |
| 03:18 ET | 4610 | 91.16 |
| 03:20 ET | 3162 | 91.175 |
| 03:21 ET | 4766 | 91.285 |
| 03:23 ET | 10017 | 91.53 |
| 03:25 ET | 2797 | 91.47 |
| 03:27 ET | 5977 | 91.49 |
| 03:30 ET | 3873 | 91.55 |
| 03:32 ET | 4210 | 91.49 |
| 03:34 ET | 5144 | 91.515 |
| 03:36 ET | 5800 | 91.55 |
| 03:38 ET | 8071 | 91.5 |
| 03:39 ET | 9336 | 91.615 |
| 03:41 ET | 11329 | 91.67 |
| 03:43 ET | 11979 | 91.585 |
| 03:45 ET | 8490 | 91.575 |
| 03:48 ET | 10719 | 91.37 |
| 03:50 ET | 18013 | 91.42 |
| 03:52 ET | 21825 | 91.65 |
| 03:54 ET | 23004 | 91.52 |
| 03:56 ET | 26313 | 91.33 |
| 03:57 ET | 30764 | 91.24 |
| 03:59 ET | 245475 | 91.2 |
Today
BioMarin Reports Record Financial Results for the First Quarter 2024, from 3 hours ago by Dow Jones
3 hours ago by Dow Jones*DJ BioMarin Pharmaceutical 1Q EPS 46c >BMRN, from 3 hours ago by Dow Jones
3 hours ago by Dow Jones
Apr 10, 2024
BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET, from 8:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
8:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
Mar 25, 2024
DJ BioMarin Pharmaceutical's Voxzogo Opportunities Being Underappreciated -- Market Talk, from 3:34PM ET on Monday Mar 25, 2024 by Dow Jones
3:34PM ET on Monday Mar 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biomarin Pharmaceutical Inc | 17.5B | 103.9x | --- |
Beigene Ltd | 15.0B | -16.9x | --- |
Alnylam Pharmaceuticals Inc | 18.4B | -40.1x | --- |
Exact Sciences Corp | 11.5B | -55.7x | --- |
Neurocrine Biosciences Inc | 14.1B | 57.2x | +62.04% |
United Therapeutics Corp | 11.0B | 12.0x | +8.22% |
Company Information
BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Voxzogo is a once daily injection analog of C-type Natriuretic Peptide (CNP) for the treatment of achondroplasia. Brineura is a recombinant human tripeptidyl peptidase 1 (TPP1) for the treatment of patients with CLN2, a form of Batten disease.
Contact Information
- Headquarters
- 105 Digital DrNOVATO, CA, United States 94949-8703
- Phone
- 415-506-6700
- Fax
- 415-382-7889
Executives
- Non-Executive Independent Chairman of the Board
- Richard Meier
- President, Chief Executive Officer, Director
- Alexander Hardy
- Chief Financial Officer, Executive Vice President - Finance
- Brian Mueller
- President - Worldwide Research and Development
- Henry Fuchs
- Executive Vice President - Global Manufacturing and Technical Operations, Chief Technical Officer
- C. Greg Guyer
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $17.5B |
|---|---|
Revenue (TTM) | $2.4B |
Shares Outstanding | 189.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.30 |
EPS | $0.88 |
Book Value | $26.25 |
P/E Ratio | 103.9x |
Price/Sales (TTM) | 7.2 |
Price/Cash Flow (TTM) | 64.2x |
Operating Margin | 5.52% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
